Literature DB >> 3279121

Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein.

M F Good1, D Pombo, W L Maloy, V F de la Cruz, L H Miller, J A Berzofsky.   

Abstract

Identification of T cell antigenic sites is critical for antisporozoite malarial vaccine design. Here, we present data that define two minimal functional T cell sites present in an immunogenic domain of the circumsporozoite protein of Plasmodium falciparum. These two sites overlap one another and correlate with polymorphic regions of the molecule. This suggests that these polymorphisms may be a result of pressure from immune T cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279121

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

Authors:  L Schofield
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy.

Authors:  Y Zevering; C Khamboonruang; M F Good
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

3.  Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans.

Authors:  P M Graves; K Bhatia; T R Burkot; M Prasad; R A Wirtz; P Beckers
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi.

Authors:  Sundos Khan; Matthew Parrillo; Andres H Gutierrez; Frances E Terry; Leonard Moise; William D Martin; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2019-03-08       Impact factor: 3.452

5.  Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.

Authors:  D J Rawlings; D C Kaslow
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.